Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2021 Mar 18;16(3):e0248426. doi: 10.1371/journal.pone.0248426

Simulating the next steps in badger control for bovine tuberculosis in England

Graham C Smith 1,*, Richard Budgey 1
Editor: Frederick Quinn2
PMCID: PMC7971561  PMID: 33735292

Abstract

Industry-led culling of badgers has occurred in England to reduce the incidence of bovine tuberculosis in cattle for a number of years. Badger vaccination is also possible, and a move away from culling was “highly desirable” in a recent report to the UK government. Here we used an established simulation model to examine badger control option in a post-cull environment in England. These options included no control, various intermittent culling, badger vaccination and use of a vaccine combined with fertility control. The initial simulated cull led to a dramatic reduction in the number of infected badgers present, which increased slowly if there was no further badger management. All three approaches led to a further reduction in the number of infected badgers, with little to choose between the strategies. We do note that of the management strategies only vaccination on its own leads to a recovery of the badger population, but also an increase in the number of badgers that need to be vaccinated. We conclude that vaccination post-cull, appears to be particularly effective, compared to vaccination when the host population is at carrying capacity.

Introduction

Bovine tuberculosis, bTB, caused by Mycobacterium bovis, is a serious economic disease of cattle and in the British Isles its management in livestock is complicated by the involvement of the European badger (Meles meles), which may be responsible for about half of all cases in cattle [1]. Widespread and sustained badger culling has been shown to reduce bTB in cattle in England [2] during an experimental trial. This led to larger areas being licenced to undertake industry-led badger control by culling with 32 areas under control by the end of 2018 and analysis of the results indicating a significant reduction in bTB in cattle [3, 4] in those areas that had undertaken control for four years.

Intra-muscular vaccination of badgers with Bacillus Calmette-Guérin (BCG) has demonstrated reduced severity and disease progression [5], and indirect protection of cubs was observed in field studies [6]. Vaccination may therefore have a role to play in disease control in badgers although it is not yet certain what level of effect this would have on bTB incidence in cattle. Simulations comparing badger culling and vaccination have shown that quicker benefits are derived from culling [79], which is not unexpected since vaccination can only remove future infected animals.

Now that a large portion of the High Risk Area for bTB is under licenced badger culling, a recent report suggested that “moving from lethal to non-lethal control of the disease in badgers is highly desirable” (i.e. vaccination) [10]. Here, we use an established simulation model [7, 11] to investigate potential exit strategies from the badger cull in England. We hypothesise that vaccinating badger post-cull will bring more immediate gains for vaccination compared to culling, than previous vaccination models which applied vaccination at carrying capacity. We therefore compare different culling options to maintain the reduced badger population size, badger trap and vaccination, and badger trap and vaccination plus fertility control. There is currently no oral vaccine available for badgers, so we assumed vaccination, and fertility control, was performed on trapped animals. This also ensures delivery to the same proportion of animals and similar effort for all strategies.

Methods

Model description

We used an established simulation model to predict the efficacy of different badger intervention methods with the objective of controlling levels of bTB (various continued proactive culling, vaccination or vaccination plus fertility control) in the badger population. The model, the rationale behind its design and development, and a sensitivity analysis are described elsewhere [7, 11, 12], with a full description of the model and parameter values in S1–S4 Appendices.

Overview

We used the latest version of an individual based model which simulated the population dynamics of wild badgers, and the dynamics of bTB. The efficacy of a range of badger control methods to reduce bTB in cattle was investigated. The model’s starting conditions were set to represent high incidence regions within England, where previous badger culling has taken place. By default, interventions occurred for five years across approximately 400 km2 within a total area of 1600 km2. Results were recorded for a range of measures inside in the intervention area, including the size of the badger population, and the levels of infection in badgers, after an initial four year badger cull to simulate an exit strategy from the licenced culling.

Organisation of the model

The model was spatially explicit with badger territories organised by combining cells on a grid representing the landscape, and all population dynamics, disease and population control processes were spatially organised within territories. The grid was wrapped round to form a torus to eliminate edge effects. The spatial area components were distributed randomly at a realistic density and shape, and new spatial configurations and initial host populations were created for each iteration. Culling-related perturbation of badgers occurred during the initial four-year cull, but, in line with previous findings, was assumed to have stopped by the end of the initial cull and did not therefore occur during any of the follow up strategies.

All events occurred within defined time steps (two month intervals). Most were controlled by parameters that were randomly varied within permitted ranges, allowing stochasticity within the model. The badger population was regulated by parameters including mortality and birth rate. The model permitted disease transmission between individuals within and between social groups to represent respective contact rates. The simulated prevalence in the badger population stabilised at 14% prior to badger control (within the range normally seen in the wild [13]). It was not necessary to simulate badger social perturbation during the follow-up control strategies as the effects of perturbation had ceased before the end of the initial four-year cull.

Badger management

The model ran for a number of years until stabilised and all data were then stored so that a number of different management options could be run from an identical starting point. A central area of ~400km2 was chosen for badger control. The proportion of compliant accessible land within the intervention area was set to 70% to maintain consistency with the minimum license requirements [14, 15]. Annual trapping efficacy was set at 70% to simulate field estimates for this method [16]. Badger social groups that were situated within or partly within participating farms in the intervention area were identified and subjected to intervention.

Intensive badger culling was simulated for four years (2016–2019), followed by alternate badger culling or vaccination which continued indefinitely. In the alternate culling scenarios, animals were removed from the population at random at a probability determined by trapping efficacy. This occurred (1) every year to simulate the current supplementary culling, (2) every second year, (3) every third year, or (4) two years followed two years without. Trapping efficacy was adjusted for each of these strategies to maintain a low badger population: for annual supplementary culling this was approximately 27%. This was compared to a strategy which simply stopped all badger culling after the four year intensive cull. For the vaccination scenario, animals were trapped with the same probability, vaccinated and released once per year. Each time a healthy badger was vaccinated, it was given a 70% probability of becoming fully and permanently protected against bTB [5]. It was assumed that vaccination had no effect on an animal that was already infected with bTB. Additionally we assumed a strategy was possible in which all animals trapped annually for vaccination were also given a fertility control agent which stopped them from breeding for life [e.g. 17].

Data output

The model was run with 100 simulations from the same starting conditions. Results from each intervention, and a scenario where no further action after the initial four-year cull was taken were recorded. Key output parameters were mean badger social group size, mean number of infected badgers per social group, mean prevalence and numbers of animals removed or vaccinated.

Results

The simulated population was recorded immediately prior to control, as though recorded by badger trapping teams. Output is shown for the central controlled area from 2015–2050, where intensive control commenced in 2016 to 2019, followed by the various exit strategies which then continued indefinitely. During the intensive cull the mean number of badgers removed in each year was 1648 (2016), 831 (2017), 525 (2018) and 390 (2019). Thus, the mean badger social group size declined rapidly during the initial cull, but thereafter it recovered to its starting size after about ten years of vaccination or no culling (Fig 1). The intermittent culling options maintained the mean social group size at a low, but variable amount, as did vaccination with fertility control. The exact level of culling in these strategies could not be easily matched to ensure they were identical, but this had no real effect on the amount of disease in the population.

Fig 1.

Fig 1

Mean badger social group size for the seven scenarios; no badger control (grey line), and intensive cull followed by no control (purple dashed line), annual supplementary culling (dark blue line), biannual culling (light blue line), culling every third year (orange line), culling for two out of four years (yellow line), vaccination (green line) and vaccination with fertility control (red line).

Since the total population size differed markedly between these exit strategies, we present the mean number of infected badgers, rather than prevalence. Following an identical reduction in the number of infected badgers during the initial cull, only the option of no further management led to a marked increase in the number of infected animals (Fig 2), but this increased at a rate much slower than the population recovery. All the remaining strategies led to a further slow decline in the number of infected badgers, and little apparent difference between them.

Fig 2.

Fig 2

Mean number of infected badgers per social group for the seven scenarios; no badger control (grey line), and intensive cull followed by no control (purple dashed line), annual supplementary culling (dark blue line), biannual culling (light blue line), culling every third year (orange line), culling for two out of four years (yellow line), vaccination (green line) and vaccination with fertility control (red line).

Each of the culling strategies removed 225 badgers per year on average, with no real difference between them (range 207–247 per year). However, the number of badgers trapped and vaccinated increased from ~300 to about 1700 per year after ten years. If combined with fertility control then the numbers trapped and vaccinated increased to a maximum of about 400 per year, due to the very limited birth rate.

Discussion

In this study we used an established model to simulate bTB dynamics in badger populations in an area of high badger density (the High Risk Area of England) after the end of a four-year intensive badger culling policy. The simulated intensive control removed 1648 badgers in year 1, decreasing to 525 in year 3, which is very similar to the mean numbers removed in the English badger control operations [1821], so we can be confident that the simulation is accurate for the intensive control period. A number of potential badger management interventions were simulated, including different ongoing or intermittent badger culling to maintain a low population, vaccination, and vaccination with fertility control [an option not yet available in the field, but under investigation, 17]. We assumed similar capture efficiency (i.e. 70%) and access to land (70%) for all strategies to ensure they were directly comparable.

Although there is evidence of a positive effect of vaccination on TB progression in badgers [6] there is no empirical data on how vaccination of badgers impacts on cattle bTB incidence, so in these scenarios we only examined the effect of badger management on bTB infection in the badger population and by extrapolation, assume that the absolute number of infected badgers is a monotonic index of infection risk in cattle.

The initial intensive cull reduced the number of infected badgers within the central controlled area to about 10% and population size to about 20% of pre-control levels. We have no way to determine the accuracy of this since population size and prevalence have not been determined in any of the current control areas. However, the exact level of reduction is not important, since this occurred prior to the exit strategies simulated here. Badger bTB prevalence was reduced to about one third of its original level by the end of the intensive cull, and continued to decrease with all exit strategies, but was dependent on population size hence the lowest prevalence was seen with vaccination only (scenario 5) as the population size increased under this strategy. Hence we reported the number of infected badgers, as this is a more accurate reflection of risk to cattle, rather than population size or prevalence. However prevalence can be estimated from a sample of badgers and as such is the measure of infection most likely to be available in the field, so in practice some estimate of population size would be needed.

All control scenarios maintained a reducing level of infection in badgers for the duration of exit strategy control, implying bTB eradication may be possible in the long term. All scenarios involving population suppression maintained the badger population at a stable level around 30% of the pre-culling level. It is possible the badger population could be maintained in the field at around this target with further modification of the removal rate or periodicity of culling, and with knowledge of exact number of animals removed and an estimate of the size of the remaining population.

The low infection levels predicted are likely to be the result of the high intensity of the initial and ongoing removal operations, and the low rate of reinvasion, even with neighbouring infected badger populations. We assumed permanent movement of badgers was limited to neighbouring territories, as these were below carrying capacity so reinvasion across the area culled was slow. An additional benefit to consider is that many of these badger control areas in England now abut with each other, further reducing immigration. If there is spatial heterogeneity in future management strategies, then the effect of immigration may become more important where an increasing population (under a no-cull or vaccination approach) abuts to an ongoing culled population.

The badger vaccination strategies offer a welfare advantage by avoiding culling. None of the culling strategies offered a welfare advantage by culling fewer animals, as the same total number was removed in each culling strategy, however cost and efficiency may be different between scenarios depending upon the number of repeat visits, time taken at each trap visit, etc.

The largest number of animals were removed during the four-year intensive culling period and subsequent removal operations were smaller.

The total number of animals trapped for vaccination was much higher than for culling as the population recovered over time. When vaccination was given with fertility control, the total number of badgers trapped was less than half the number trapped using vaccination on its own.

All BCG vaccination simulations assumed complete individual protection for a portion of vaccinated animals. The current evidence suggests that while this is true for some, others may still become infected but show reduced progression. This may reduce the overall efficacy of vaccination compared to culling and to the model is being adjusted based on the latest data to examine this in more detail.

Overall, the model output during the intensive cull is very similar to the field data, suggesting our starting point for future badger management is accurate. If no badger management is performed, then the population recovers in about 10 years but the absolute number of infected badgers takes much longer to increase. All management approaches could maintain the badger density at less than half of its carrying capacity, except for vaccination, where the population also recovered in about 10 years. All management strategies were capable of reducing the absolute number of infected badgers over time, with little to choose between them in this metric. This includes vaccination during which the population size increases. Therefore the main difference is that vaccination does not involve killing any badgers, although the number of badger to be vaccinated will increase over time. The cost in the short term would be similar for all the above strategies, but note that the increase in population size for a vaccinated population would slowly increase the numbers trapped that require a vaccine, which would slightly increase the cost. In the longer term vaccination combined with fertility control may also be a useful management tool to retain a reduced population size.

Supporting information

S1 Appendix. Model variables (temporal settings).

(DOC)

S2 Appendix. Model variables (spatial settings).

(DOC)

S3 Appendix. Model variables (badger parameters).

(DOC)

S4 Appendix. Model processes (submodels).

(DOC)

Data Availability

All relevant data are within the paper and its Supporting Information files.

Funding Statement

This work was funded by Defra (Department for Environment and Rural Affairs) as a request to investigate the topic. They played no role in study design, analysis or drafting the paper.

References

Decision Letter 0

Frederick Quinn

7 Oct 2020

PONE-D-20-26898

Simulating the next steps in badger control for bovine tuberculosis in England

PLOS ONE

Dear Dr. Smith,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Frederick Quinn

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This useful and timely analysis compares different models of controlling badger populations, to reduce risk of BTB spread to cattle. The main claims of the paper are that the 3 control approaches are projected to result in similar reduction in infected badgers, based on statistical modeling.

The data and analyses support the claims.

However, the manuscript could be revised to make it clear to non-specialists in the field.

For example, on page 2 authors could elaborate further on reference 10 about the desirability of non-lethal control models. BCG vaccination protocols could be briefly explained as 2 options (injection versus oral baiting) could be utilized.

The Discussion ends without a summary of conclusions, which are found only in the Abstract. Assuming the 3 control methods are equivalent, then the authors should advance how wildlife managers would make a selection, i.e. cost analyses as well.

Reviewer #2: The modeling work presented in the paper addresses the important question of the benefit of deploying vaccines to control TB in badgers and cattle in the UK, under the current situation of industry-deployed cull.

The vaccine considered for the model is injectable (by IM delivery), which should be mentioned (for ex on L103 and L157) since it implies the need for trapping badgers, contrarily to oral vaccination which could be more widely deployed and potentially reach a larger range of animals/groups.

The model is based on the TB situation in the UK, which should be specified more in the paper, for exemple l41 “it is not certain what level of effect this would have on bTB incidence in cattle in the UK”.

The output of number of infected badgers only is surprising, especially as the author mentions in L173-174 that prevalence is the measure most likely to be available in the field. The author may be more explicit on the rational for choosing this output, possibly that the risk to cattle may be expected to be proportional to the number of infected animals, not to their density, and this should be discussed.

Finally, the overall conclusion could be clearer. Is vaccination a favorable strategy compared with culling?

Corrections and new formulations are suggested below:

L14: Justify why the prevalence of bTB in badger population was fixed at 14%

L108, is the fertility control treatment vaccination given yearly in the animals trapped for injectable vaccination, as suggested in the legend of fig1?

Rephrase L173-174.

L170: replace reduce by decrease

L175: add “in badgers” after “infection”

L176: add “bTB” before eradication

Rephrase L179-180.

Rephrase L184 from “so reinvasion was slow”.

L184, be more specific about the strategy with additional benefit. The author should also mention the lack of immigration in the context of vaccination, given the return of the population number to social equilibrium between the groups.

L187 The author mentions the (non existant) welfare advantage of culling strategies but not of vaccination exit strategy involving vaccination .

L192, add” than for culling” after “was much higher”

L193, Replace “whereas” by “when”, rephrase after “this resulted”

L195, add “with BCG” after vaccination and “individual” before protection, and “vaccinated” before animals

L198, be more precise in term of other work in hand to examine the overall efficacy of vaccination

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Frederick Quinn

26 Feb 2021

Simulating the next steps in badger control for bovine tuberculosis in England

PONE-D-20-26898R1

Dear Dr. Smith,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Frederick Quinn

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Frederick Quinn

9 Mar 2021

PONE-D-20-26898R1

Simulating the next steps in badger control for bovine tuberculosis in England  

Dear Dr. Smith:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Frederick Quinn

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Model variables (temporal settings).

    (DOC)

    S2 Appendix. Model variables (spatial settings).

    (DOC)

    S3 Appendix. Model variables (badger parameters).

    (DOC)

    S4 Appendix. Model processes (submodels).

    (DOC)

    Attachment

    Submitted filename: Godfray exit Response to referees.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES